Payment overview · 2025
General Payments
$397.63
23 reported records · 4 companies
Healthcare provider profile · identity verified
James Michael Rogan, MD
Allopathic & Osteopathic Physicians|Family Medicine · ATLANTA, GA · NPI 1982704300
Verified facts
What the public records show
CMS Open Payments records show James Michael Rogan, MD received $397.63 in general payments during 2025 across 23 reported records.
ACADIA Pharmaceuticals Inc accounted for 54.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 48 claims for Arexvy by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 89 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 65 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $216.64 | 54.5% | 11 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $142.50 | 35.8% | 10 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $20.24 | 5.1% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $18.25 | 4.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $397.63 | 23 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $216.64 | 11 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $142.50 | 10 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $20.24 | 1 | 2025 |
Source payment records
|
|||||
| BENLYSTA Normalized: benlysta |
Biological | GlaxoSmithKline, LLC. | $18.25 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | AREXVY open payments reported associated product |
CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445 |
Arexvy · 2024 Exact normalized brand match · 1 Part D row |
48 | 48 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
89 | 71 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
65 | 12 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 3952 | 176 |
| Amlodipine Besylate | Amlodipine Besylate | 2341 | 159 |
| Tamsulosin Hcl | Tamsulosin Hcl | 2227 | 105 |
| Gabapentin | Gabapentin | 1902 | 124 |
| Furosemide | Furosemide | 1673 | 126 |
| Lisinopril | Lisinopril | 1658 | 98 |
| Divalproex Sodium | Divalproex Sodium | 1612 | 72 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1260 | 112 |
| Potassium Chloride | Potassium Chloride | 1255 | 91 |
| Clopidogrel | Clopidogrel Bisulfate | 1211 | 76 |
| Eliquis | Apixaban | 1172 | 101 |
| Finasteride | Finasteride | 1162 | 44 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1142 | 112 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1084 | 89 |
| Carvedilol | Carvedilol | 909 | 60 |
| Omeprazole | Omeprazole | 784 | 57 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 775 | 85 |
| Metformin Hcl | Metformin Hcl | 723 | 53 |
| Baclofen | Baclofen | 707 | 36 |
| Losartan Potassium | Losartan Potassium | 693 | 48 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 655 | 102 |
| Sertraline Hcl | Sertraline Hcl | 641 | 71 |
| Duloxetine Hcl | Duloxetine Hcl | 638 | 45 |
| Tramadol Hcl | Tramadol Hcl | 630 | 146 |
| Memantine Hcl | Memantine Hcl | 629 | 59 |
| Montelukast Sodium | Montelukast Sodium | 617 | 29 |
| Levetiracetam | Levetiracetam | 576 | 34 |
| Trazodone Hcl | Trazodone Hcl | 555 | 63 |
| Mirtazapine | Mirtazapine | 528 | 60 |
| Spironolactone | Spironolactone | 504 | 26 |
| Famotidine | Famotidine | 479 | 52 |
| Quetiapine Fumarate | Quetiapine Fumarate | 476 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 430 | 27 |
| Metoprolol Succinate | Metoprolol Succinate | 411 | 46 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 380 | 23 |
| Midodrine Hcl | Midodrine Hcl | 370 | 27 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 356 | 23 |
| Risperidone | Risperidone | 355 | 22 |
| Amiodarone Hcl | Amiodarone Hcl | 354 | 23 |
| Donepezil Hcl | Donepezil Hcl | 352 | 53 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 336 | 44 |
| Buspirone Hcl | Buspirone Hcl | 324 | 29 |
| Paroxetine Hcl | Paroxetine Hcl | 295 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 289 | 24 |
| Xarelto | Rivaroxaban | 287 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 285 | 19 |
| Fenofibrate | Fenofibrate Nanocrystallized | 277 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 277 | 25 |
| Escitalopram Oxalate | Escitalopram Oxalate | 274 | 31 |
| Allopurinol | Allopurinol | 271 | 21 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 257 | 31 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 242 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 233 | 37 |
| Myrbetriq | Mirabegron | 228 | 12 |
| Aripiprazole | Aripiprazole | 219 | 17 |
| Meloxicam | Meloxicam | 213 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 212 | 14 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 205 | suppressed |
| Sucralfate | Sucralfate | 197 | 16 |
| Oxcarbazepine | Oxcarbazepine | 195 | suppressed |
| Amantadine | Amantadine Hcl | 192 | 13 |
| Alendronate Sodium | Alendronate Sodium | 183 | 23 |
| Januvia | Sitagliptin Phosphate | 183 | 13 |
| Topiramate | Topiramate | 179 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 177 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 176 | suppressed |
| Alprazolam | Alprazolam | 175 | 31 |
| Lacosamide | Lacosamide | 163 | 22 |
| Oxycodone Hcl | Oxycodone Hcl | 158 | 34 |
| Clonazepam | Clonazepam | 155 | 19 |
| Dutasteride | Dutasteride | 151 | suppressed |
| Glipizide | Glipizide | 147 | 12 |
| Constulose | Lactulose | 145 | 50 |
| Lorazepam | Lorazepam | 145 | 47 |
| Diltiazem Hcl | Diltiazem Hcl | 143 | suppressed |
| Carbamazepine | Carbamazepine | 138 | suppressed |
| Pregabalin | Pregabalin | 136 | 24 |
| Torsemide | Torsemide | 135 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 133 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 132 | 56 |
| Clonidine Hcl | Clonidine Hcl | 132 | 13 |
| Novolog Flexpen | Insulin Aspart | 132 | 18 |
| Latanoprost | Latanoprost | 131 | 24 |
| Brilinta | Ticagrelor | 124 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 124 | 22 |
| Cephalexin | Cephalexin | 123 | 53 |
| Fluconazole | Fluconazole | 122 | 52 |
| Terazosin Hcl | Terazosin Hcl | 120 | suppressed |
| Simvastatin | Simvastatin | 115 | 16 |
| Levofloxacin | Levofloxacin | 113 | 45 |
| Oxybutynin Chloride | Oxybutynin Chloride | 113 | suppressed |
| Nystatin | Nystatin | 112 | 51 |
| Fluticasone Propionate | Fluticasone Propionate | 111 | 44 |
| Doxycycline Hyclate | Doxycycline Hyclate | 110 | 41 |
| Jardiance | Empagliflozin | 110 | 15 |
| Ezetimibe | Ezetimibe | 108 | 13 |
| Labetalol Hcl | Labetalol Hcl | 108 | suppressed |
| Temazepam | Temazepam | 108 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 103 | 49 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 99 | 33 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 98 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 96 | 14 |
| Ondansetron Odt | Ondansetron | 96 | 34 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 95 | 64 |
| Irbesartan | Irbesartan | 93 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 93 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 93 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 92 | 14 |
| Novolog | Insulin Aspart | 92 | 18 |
| Olanzapine | Olanzapine | 92 | 19 |
| Humulin R | Insulin Regular, Human | 91 | 15 |
| Metformin Hcl Er | Metformin Hcl | 90 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 89 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 89 | 71 |
| Lamotrigine | Lamotrigine | 87 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 87 | 15 |
| Valsartan | Valsartan | 86 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 84 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 83 | 13 |
| Acyclovir | Acyclovir | 79 | suppressed |
| Perphenazine | Perphenazine | 78 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 77 | 34 |
| Sevelamer Carbonate | Sevelamer Carbonate | 77 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 76 | 11 |
| Propranolol Hcl | Propranolol Hcl | 76 | suppressed |
| Atenolol | Atenolol | 75 | suppressed |
| Bumetanide | Bumetanide | 73 | suppressed |
| Methotrexate | Methotrexate Sodium | 73 | suppressed |
| Fenofibrate | Fenofibrate | 71 | suppressed |
| Azithromycin | Azithromycin | 68 | 26 |
| Lansoprazole | Lansoprazole | 66 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 65 | 12 |
| Ibuprofen | Ibuprofen | 63 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 63 | suppressed |
| Calcitriol | Calcitriol | 62 | suppressed |
| Naproxen | Naproxen | 61 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 60 | 19 |
| Tresiba Flextouch U-100 | Insulin Degludec | 59 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 59 | 26 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 57 | 11 |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 57 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 56 | suppressed |
| Prednisone | Prednisone | 56 | 26 |
| Bupropion Hcl | Bupropion Hcl | 55 | 11 |
| Glimepiride | Glimepiride | 55 | suppressed |
| Bupropion Xl | Bupropion Hcl | 54 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 54 | suppressed |
| Entresto | Sacubitril/Valsartan | 54 | suppressed |
| Scopolamine | Scopolamine | 54 | suppressed |
| Chlorthalidone | Chlorthalidone | 53 | suppressed |
| Linzess | Linaclotide | 53 | 13 |
| Nabumetone | Nabumetone | 52 | suppressed |
| Novolin R | Insulin Regular, Human | 52 | 11 |
| Risperdal Consta | Risperidone Microspheres | 52 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 52 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 52 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 51 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 49 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 48 | 48 |
| Methimazole | Methimazole | 47 | suppressed |
| Fentanyl | Fentanyl | 46 | suppressed |
| Gemtesa | Vibegron | 46 | suppressed |
| Methocarbamol | Methocarbamol | 46 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 46 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 45 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 44 | suppressed |
| Nifedipine Er | Nifedipine | 43 | suppressed |
| Movantik | Naloxegol Oxalate | 42 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 42 | suppressed |
| Ozempic | Semaglutide | 41 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 41 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 40 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 40 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 40 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 40 | 23 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 39 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 39 | suppressed |
| Levemir | Insulin Detemir | 38 | 14 |
| Lithium Carbonate | Lithium Carbonate | 38 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 38 | suppressed |
| Ranolazine Er | Ranolazine | 38 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 38 | suppressed |
| Amoxicillin | Amoxicillin | 37 | 21 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 36 | 22 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 36 | 13 |
| Moxifloxacin | Moxifloxacin Hcl | 36 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 36 | suppressed |
| Rexulti | Brexpiprazole | 35 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 34 | 11 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 33 | 14 |
| Levemir Flexpen | Insulin Detemir | 33 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 32 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 32 | suppressed |
| Ketoconazole | Ketoconazole | 32 | 18 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 31 | suppressed |
| Haloperidol | Haloperidol | 31 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 31 | 22 |
| Solifenacin Succinate | Solifenacin Succinate | 31 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 30 | suppressed |
| Timolol Maleate | Timolol Maleate | 30 | suppressed |
| Progesterone | Progesterone, Micronized | 28 | suppressed |
| Abacavir-Lamivudine | Abacavir Sulfate/Lamivudine | 27 | suppressed |
| Cilostazol | Cilostazol | 27 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 27 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 27 | suppressed |
| Folic Acid | Folic Acid | 27 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 27 | 13 |
| Verapamil Er | Verapamil Hcl | 27 | suppressed |
| Hydroxyurea | Hydroxyurea | 26 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 26 | suppressed |
| Tetrabenazine | Tetrabenazine | 26 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 26 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 25 | 19 |
| Colchicine | Colchicine | 25 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 25 | suppressed |
| Linezolid | Linezolid | 25 | 15 |
| Clobetasol Propionate | Clobetasol Propionate | 24 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 24 | suppressed |
| Paliperidone Er | Paliperidone | 24 | suppressed |
| Phenobarbital | Phenobarbital | 24 | suppressed |
| Erythromycin | Erythromycin Base | 23 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 23 | 21 |
| Nitroglycerin | Nitroglycerin | 23 | 21 |
| Primidone | Primidone | 23 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 23 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 22 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 22 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 22 | 14 |
| Lactulose | Lactulose | 22 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 22 | suppressed |
| Tradjenta | Linagliptin | 22 | suppressed |
| Acetazolamide | Acetazolamide | 21 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 21 | suppressed |
| Diphenhydramine Hcl | Diphenhydramine Hcl | 21 | 11 |
| Lurasidone Hcl | Lurasidone Hcl | 21 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 20 | 15 |
| Insulin Aspart | Insulin Aspart | 20 | suppressed |
| Metronidazole | Metronidazole | 20 | 11 |
| Danazol | Danazol | 19 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 19 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 19 | suppressed |
| Phenytoin | Phenytoin | 19 | suppressed |
| Premarin | Estrogens, Conjugated | 19 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 19 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 18 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 18 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 18 | suppressed |
| Glyburide | Glyburide | 18 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 18 | suppressed |
| Mirabegron Er | Mirabegron | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 17 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 17 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 17 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 17 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 16 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 16 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 16 | suppressed |
| Glipizide Er | Glipizide | 16 | suppressed |
| Pulmicort Flexhaler | Budesonide | 16 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 16 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 15 | suppressed |
| Eszopiclone | Eszopiclone | 15 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 15 | suppressed |
| Lumigan | Bimatoprost | 15 | suppressed |
| Risperidone Er | Risperidone Microspheres | 15 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Ciclopirox | Ciclopirox | 14 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 14 | suppressed |
| Isoniazid | Isoniazid | 14 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Rifampin | Rifampin | 14 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Mercaptopurine | Mercaptopurine | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 12 | suppressed |
| Meropenem | Meropenem | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | suppressed |
| Nucynta | Tapentadol Hcl | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Tivicay | Dolutegravir Sodium | 12 | suppressed |
| Admelog | Insulin Lispro | 11 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Clonidine | Clonidine | 11 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 11 | suppressed |
| Nystop | Nystatin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $397.63 · 23 records | ACADIA Pharmaceuticals Inc | AUSTEDO XR, BENLYSTA, INGREZZA, NUPLAZID | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error